Pacemaker implantation in active COVID-19 patients: experience of a city hospital
Aim. To analyze the experience of a multidisciplinary hospital in the implantation of pacemaker (PM) in patients with COVID-19, to evaluate predictors and the incidence of complications and adverse outcomes. Methods. One-hundred twenty five patients with active COVID-19 underwent PM implantation/rep...
Saved in:
Published in: | Vestnik aritmologii Vol. 29; no. 4; pp. 17 - 25 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
08-12-2022
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aim.
To analyze the experience of a multidisciplinary hospital in the implantation of pacemaker (PM) in patients with COVID-19, to evaluate predictors and the incidence of complications and adverse outcomes.
Methods.
One-hundred twenty five patients with active COVID-19 underwent PM implantation/replacement during the period from 04/01/2020 to 11/30/2021 at the Department of Cardiovascular Surgery of the City Multidisciplinary Hospital, reprofiling to provide medical care to patients with COVID-19. The presence of SARS-CoV-2 virus was confirmed by a positive result of the polymerase chain reaction performed the day before the procedure.
Results.
Median age of patients was 81 [73-86] years. Indications for PM in most cases were atrioventricular block of II-III degrees (n=71, 56.8%), sick sinus syndrome (n=30, 24%). The PM was replaced in 20 (16%) patients. Of the 125 patients in the study survey, the 30-day complication rate was 12%, and the 180-day mortality rate was 16.8%.
Conclusion.
Patients with active COVID-19 had an increased level of complications and mortality rates after PM implantation/replacement. It is necessary to take these risks into consideration to better select patients with active COVID-19 infection. |
---|---|
ISSN: | 1561-8641 2658-7327 |
DOI: | 10.35336/VA-2022-4-03 |